News and Announcements
Universal Biosensors Annual Report 2016
- Published May 12, 2016 4:18PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
May 12th, ASX Announcement
Chairman’s Letter
“Our company is a proud developer of medical diagnostic systems that make a difference to people’s lives around the world every day. Through our efforts, the technology we have developed with our partners is helping people with diabetes who need to manage their blood glucose levels through LifeScan OneTouch® Verio®, one of the world’s most popular blood glucose monitoring devices. And since December 2014, patients managing their use of the blood thinning drug warfin with the Siemens Xprecia Stride™ are using test strips developed and made at our Rowville facility in Melbourne, Australia.
To view the full report please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
